
Iyi ngingo itanga amakuru yuzuye kubijyanye no kuvura, guhanura, n'ibitaro biyoboye inzobere kanseri y'impyiko kanseri (RCC). Turasesengura uburyo butandukanye bwo kuvura, ibintu bigira ingaruka ku guhanura, hamwe nubushobozi bwo kubona ubuvuzi bwiza.
Kanseri y'impyiko (RCC) ni ubwoko bwa kanseri y'impyiko ikomoka ku murongo w'uduce duto two mu mpyiko. Ifite igice kinini cya kanseri yimpyiko kandi irashobora gushyirwa mubice bitandukanye bitewe ningirabuzimafatizo. Kumenya hakiri kare no kuvurwa byihuse nibyingenzi kugirango bigerweho neza.
RCC ikorwa ukurikije urugero kanseri ikwirakwira. Gutegura ni ngombwa mu kumenya ingamba zikwiye zo kuvura no guhanura ibizaba. Ibyiciro bitangirira ku ndwara zanduye (Icyiciro cya I) kugeza ku ndwara ziterwa na metastatike (Icyiciro cya IV), buri cyiciro kigira ingaruka ku buryo bwo kuvura no ku mibereho. Gusobanukirwa uburyo bwo kubika ni ngombwa kubarwayi n'imiryango yabo.
Kubaga nubuvuzi busanzwe bwa RCC bwaho, akenshi burimo gukuramo impyiko zanduye (nephrectomy radical). Igice cya nephrectomy, aho igice cya kanseri cyonyine kivanyweho, gishobora kuba amahitamo mubihe bimwe. Guhitamo kubaga biterwa nibintu byinshi, harimo aho ikibyimba giherereye.
Ubuvuzi bugenewe bugenewe kwibasira cyane kanseri ya kanseri mugihe hagabanijwe kwangiza ingirabuzimafatizo. Ubu buvuzi bwahinduye imiyoborere ya RCC yateye imbere, itanga ubuzima bwiza. Ingero zirimo sunitinib, pazopanib, na axitinib. Guhitamo imiti igamije gushingira kumiterere yihariye yibibyimba nubuzima bwumurwayi muri rusange.
Immunotherapy ikoresha umubiri wumubiri urwanya kanseri. Inzitizi za Checkpoint, nka nivolumab na ipilimumab, zerekanye intsinzi idasanzwe mu kuvura RCC yateye imbere. Iyi miti ikora ihagarika poroteyine zibuza umubiri kwirinda indwara ya kanseri. Immunotherapy irashobora gukoreshwa wenyine cyangwa ifatanije nubundi buvuzi.
Imiti ivura imirasire ikoresha imirasire yingufu nyinshi kugirango yice selile. Nubwo atariwo muti wibanze kuri RCC, irashobora gukoreshwa mubihe byihariye, nko gucunga ibisubirwamo cyangwa ibimenyetso byerekana indwara zateye imbere.
Ibintu byinshi bigira uruhare mu kumenyekanisha kwa kanseri y'impyiko, harimo icyiciro cya kanseri mugupima, urwego rwibibyimba, kuba metastasis, nubuzima bwumurwayi muri rusange. Kumenya hakiri kare no kuvura bikabije bizamura cyane ubuzima. Kwitaho buri gihe nabyo ni ngombwa mugukurikirana ibisubirwamo cyangwa gutera imbere.
| Ikintu | Ingaruka ku Kumenyekanisha |
|---|---|
| Icyiciro cyo Gusuzuma | Ibyiciro byambere mubisanzwe bifite prognoza nziza. |
| Tumor Grade | Ibibyimba byo murwego rwohejuru birakaze kandi bifite prognoz mbi. |
| Metastasis | Kubaho kwa metastasis byangiza cyane prognoz. |
Guhitamo ibitaro bifite ubuhanga bwo kuvura kanseri y'impyiko ni ngombwa kubisubizo byiza. Shakisha ibigo bifite inararibonye za urologiste, oncologiste, hamwe nitsinda ryabigenewe byinshi. Reba ibitaro bifite uburyo bwo kuvura buhanitse, nko kubaga robotic no kubona ibizamini byo kwa muganga. Gusoma ibyasuzumwe n'abarwayi no kubohereza kubashinzwe ubuzima nabyo birashobora gufasha.
Ku barwayi bashaka urwego rwo hejuru kanseri y'impyiko kwivuza, Shandong Baofa Ikigo Cyubushakashatsi Kanseri itanga ubuvuzi buhanitse hamwe nubuhanga bugezweho. Ubwitange bwabo kubuvuzi bushingiye kubarwayi butuma bahitamo kwambere kuvura kanseri yuzuye.
Inshingano: Aya makuru agamije uburezi gusa kandi ntabwo agizwe ninama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa kugira ngo zisuzume kandi zivure indwara iyo ari yo yose.